LOUISVILLE, Ken., April 1, 2019 /PRNewswire/ -- US WorldMeds has announced that Sloan Pharma, S.a.r.l., a subsidiary of US WorldMeds Holdings, LLC, has received approval from the U.S. Food and Drug ...
Alfasigma USA Inc., which has a commercial hub in Bedminster, announced on Monday it has acquired the brand Zelnorm (tegaserod), a prescription pharmaceutical treatment for irritable bowel syndrome ...
BEDMINSTER, N.J.--(BUSINESS WIRE)--Alfasigma USA, Inc. today announced that ZELNORM™ (tegaserod) is now available in the United States as a prescription pharmaceutical treatment for irritable bowel ...
US WorldMeds announced that the Food and Drug Administration (FDA) has approved the reintroduction of Zelnorm (tegaserod) for the treatment of irritable bowel syndrome with constipation (IBS-C) in ...
Novartis suspends US marketing and sales of Zelnorm(R) in response to request from FDA Retrospective analysis of pooled clinical trial data shows numerical imbalance in cardiovascular events in ...
High-profile, quick-growing IBS drug shelved because of cardio risks. FDA has asked Novartis to pull Zelnorm (tegaserod) from the market five years after its approval, eliciting a swift and surprised ...
BEDMINSTER, N.J., July 23, 2020 (GLOBE NEWSWIRE) -- Alfasigma USA, Inc. today announced a strategic deal with Indegene, Inc., a global life sciences and healthcare solutions provider, to co-promote ...
ZELNORM approved by FDA in March 2019 after thorough safety review Alfasigma USA has begun national reintroduction of ZELNORM to prescribers ZELNORM now widely available through wholesale channels and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results